Sunwels Co.,Ltd. (TYO:9229)
877.00
-8.00 (-0.90%)
Aug 13, 2025, 3:30 PM JST
Sunwels Revenue
Sunwels had revenue of 6.61B JPY in the quarter ending June 30, 2025, a decrease of -0.47%. This brings the company's revenue in the last twelve months to 26.47B, up 19.65% year-over-year. In the fiscal year ending March 31, 2025, Sunwels had annual revenue of 26.50B with 31.78% growth.
Revenue (ttm)
26.47B
Revenue Growth
+19.65%
P/S Ratio
1.08
Revenue / Employee
8.02M
Employees
3,302
Market Cap
28.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 26.50B | 6.39B | 31.78% |
Mar 31, 2024 | 20.11B | 6.87B | 51.91% |
Mar 31, 2023 | 13.24B | 5.06B | 61.93% |
Mar 31, 2022 | 8.17B | 2.77B | 51.26% |
Mar 31, 2021 | 5.40B | 1.03B | 23.41% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.22B |
Takeda Pharmaceutical Company | 4,480.25B |
HOYA Corporation | 876.09B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |